Anthem and Eli Lilly have partnered in a collaborative initiative to tackle the high cost of prescription drugs through value-based pricing models, reports Bloomberg BNA. “While the rest of the ...

With drug prices rising faster than inflation and outpacing many other health care costs, policy makers are under increasing pressure to find sustainable solutions that balance patient access, ...

Policy complexity and cumulative impact create uncertainty, affecting investment and innovation in cancer therapies. Precision medicine advancements require policy evolution to support biomarker ...

As health care moves toward a value-based payment model, the pharmacy benefit is going in the opposite direction, one that places unit cost over clinical appropriateness. Have you ever used your drug ...

Pressure to slash drug prices from both the Democratic and Republican presidential candidates, as well as leaders and consumer advocates around the globe, could spur changes to the drug pricing model, ...